Course handouts are now available
Click here
Come to London
WATCH to find out why
Site updates:
Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.
Posters
(results will display both Free Papers & Poster)
Small aperture inlay for treating emmetropic presbyopes: three year results
Poster Details
First Author: J.Vukich USA
Co Author(s):
Abstract Details
Purpose:
To evaluate the safety and efficacy of a small aperture corneal inlay for the treatment of presbyopia.
Setting:
24 sites (US, Europe, and Asia-Pacific)
Methods:
Prospective, non-randomized clinical trial of 154 naturally occurring emmetropic presbyopes treated with a small aperture corneal inlay. Patients were between the ages of 45 and 60. Additional inclusion criteria were uncorrected near visual acuity (UCNVA) of worse than 20/40 and better than 20/100 and a best-corrected distance visual acuity (BCDVA) ≥ 20/20 in both eyes, with a spherical equivalent between +0.50 D to -0.75 D. The inlay was implanted monocularly in the non-dominant eye into a femtosecond laser created pocket using laser settings equivalent to or less than of 6X6 spot/line. Visual acuity, refractive stability and satisfaction were evaluated.
Results:
Mean UCNVA improved 5 lines from J8 at pre-op to J2 at 3 years post-op. 73% of the patients achieved UCNVA of J3 or better and 53% were J2 or better. Mean uncorrected distance visual acuity was virtually unchanged from 20/18.5 to 20/20. 92% of patients were 20/25 or better at 3-years post-op. Mean MRSE changed from +0.02 ± 0.28D to +0.14 ± 0.72D. 96% were within ± 1.00D of intended target. No patient sustained a loss of 2 or more lines of BCDVA at 3 years. 97% of patients would elect to have this procedure again.
Conclusions:
Implantation of a small aperture inlay into a lamellar pocket improves near visual acuity while retaining good distance vision over the long-term. Results are stable and patient satisfaction is high. FINANCIAL INTEREST: One of more of the authors... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented